Navigation Links
Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
Date:1/9/2009

National Cord Blood Program Provides Stem Cells

NEW YORK, Jan. 9 /PRNewswire-USNewswire/ -- A two year old child from Florida is free of signs of juvenile myelomonocytic leukemia (JMML), a very rare form of pediatric leukemia, seventeen months after receiving a transplant with cord blood from the National Cord Blood Program (NCBP) of the New York Blood Center's Howard P. Milstein National Cord Blood Center.

Juvenile myelomonocytic leukemia generally affects children under the age of five and comprises less than one percent of infant leukemias. The prognosis for JMML is generally poor and most children with JMML die before reaching the age of three.

Adolfo Gonzalez was diagnosed with JMML when he was thirteen months old. "Adolfo Gonzalez would most likely not be alive today if it weren't for the cord blood transplant," said Gary Kleiner, M.D., Ph.D., pediatric immunologist at the University of Miami School of Medicine. "The mother who donated her cord blood to the public cord blood bank at New York's National Cord Blood Program basically saved his life."

Adolfo's treatment included chemotherapy to destroy his leukemia cells followed by a cord blood stem cell transplant from NCBP. He did endure some complications, but approximately two weeks after he had received the infusion of the stem cells, his white cell count began to return to normal. Adolfo has no signs of any leukemia seventeen months later.

"We're thrilled that NCBP, the first and largest public cord blood bank in the world, was able to help Adolfo and his family," said NCBP Chief Scientist Pablo Rubinstein, M.D. "He's among almost 3,000 people who have received a match from the 50,000 units we've frozen since 1992."

Note: WCTV in Tallahassee, Florida conducted an in-depth interview with Dr. Kleiner. A full transcript, along with Dr. Kleiner's media contact information, is available at this link:

http://www.wctv.tv/medicalminute/interviewheadlines/36761699.html

About National Cord Blood Program (NCBP)

Launched in 1992, NCBP was the first established cord blood bank to collect, process, test and store cord blood units and make them available for transplantation for any patient in need for a hematopoietic stem cell transplant. NCBP accepts requests from all over the world. Cord blood units can be accessed through the NETCord database, and now through the Single Point of Access (SPA) of the National Marrow Donor Program.

About New York Blood Center (NYBC)

New York Blood Center (NYBC) is one of the nation's largest non-profit, community-based blood centers. NYBC has been providing blood, transfusion products and services to patients in greater New York since 1964. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals and transfusion medicine physicians.

    Contact: Christine Dingfelder
    (212) 570-3227 Office / (917) 763-1648 Cell



'/>"/>
SOURCE New York Blood Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend
2. Lee County School District online wellness program inspires employees to walk 200 million steps in 2 months
3. Mammogram most effective 12 months after radiation treatment
4. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
5. Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
6. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
7. International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results
8. Mindray Announces 2008 Third Quarter and Nine Months Results
9. Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud
10. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
11. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study ... decade, student well-being has seriously declined. "When disenfranchised youth from the heart of ... Islamic State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist and ... Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in ... annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... deionized water from the same place. From 101 Water Texas, here are the ... and staff can enjoy a continuous supply of pure, fresh, oxygenated water, with ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the Year, ... providing information destruction , recycling, and compliance services to businesses throughout ...
(Date:4/21/2017)... ... 2017 , ... An April 10 article in the Daily Mail ... a great deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, ... remove decayed dental matter, and that teeth were then filled with bitumen, a substance ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
(Date:4/18/2017)... DUBLIN , April 18, 2017 Research ... Devices Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at ... The report, Global Arthroscopy Devices Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: